跳至主要內容

藥物交互作用

Rifapentine + Sofosbuvir-velpatasvir-voxilaprevir

嚴重程度: 禁忌併用

Rifapentine and Sofosbuvir-velpatasvir-voxilaprevir: contraindicated interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Rifapentine is an inducer of CYP enzymes and P-glycoprotein and can markedly lower plasma concentrations of sofosbuvir, velpatasvir and voxilaprevir. This may lead to loss of antiviral activity and failure to achieve sustained virologic response.

用白話說明這項交互作用的意義

Rifapentine and Sofosbuvir-velpatasvir-voxilaprevir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Rifapentine belongs to Anti Bacterial; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

證據等級: High

為什麼會發生

Induction of intestinal and hepatic CYP3A4 and P-glycoprotein by rifapentine increases clearance and reduces absorption of the HCV agents.

處置方式

Do not coadminister; rifamycin inducers are not recommended with this regimen. Choose an alternative tuberculosis regimen or delay HCV therapy until rifapentine is completed.

可向藥師詢問的問題

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Rifapentine 與 Sofosbuvir-velpatasvir-voxilaprevir 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Rifapentine with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as contraindicated. Rifapentine and Sofosbuvir-velpatasvir-voxilaprevir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Rifapentine is an inducer of CYP enzymes and P-glycoprotein and can markedly lower plasma concentrations of sofosbuvir, velpatasvir and voxilaprevir. This may lead to loss of antiviral activity and failure to achieve sustained virologic response.

How serious is the interaction between Rifapentine and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not coadminister; rifamycin inducers are not recommended with this regimen. Choose an alternative tuberculosis regimen or delay HCV therapy until rifapentine is completed.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入